ThomasByronSneedMD

PubMed

• A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.
  Montalban-Bravo G, Huang X, Jabbour E, Borthakur G, DiNardo CD, Pemmaraju N, Cortes J, Verstovsek S, Kadia T, Daver N, Wierda W, Alvarado Y, Konopleva M, Ravandi F, Es...> ;Leukemia. 2016-11-18
• 830 citations
  Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
  Marina Konopleva, Rooha Contractor, Twee Tsao, Ismael Samudio, Peter P. Ruvolo, Shinichi Kitada, Xingming Deng, Dayong Zhai, Yue Xi Shi, Thomas Sneed, Monique Verhaege...> ;Cancer Cell. 2006 Nov 1
• Targeted therapy of AML new concepts.
  Andreeff, M., Milella, M., Carter, B. Z., Tabe, Y., Ricciardi, M. R., Sneed, T., Ruvolo, P., Contractor, R., Tsao, T., Schober, W., Evans, R., McQueen, T., Zeng, Z., K...> ;Ann Hematol. 2004
• 93 citations
  The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase.
  Thomas B. Sneed, Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, R N Mary Beth Rios, B. Nebiyou Bekele, Xian Zhou, R N Debra Resta, William G. Wierda, Stefan Faderl, Fr...> ;Cancer. 2004 Jan 1
• c-myc transcription is initiated from P0 in 70% of patients with multiple myeloma.
  Hoover, R. G., Kaushal, V., Lary, C., Travis, P., Sneed, T.> ;Curr Top Microbiol Immunol. 1995
• 33 citations
  Interleukin-6 Regulates Expression of the Syndecan-1 Proteoglycan on B Lymphoid Cells
  Thomas B. Sneed, Deborah J. Stanley, Lanne A. Young, Ralph D. Sanderson> ;Cellular Immunology. 1994 Feb 1
• Join now to see all